Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020-October 2021-论文-万方医学网

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020-October 2021

导出原文传递

翻译打印收藏纠错

作者： Moro, Pedro L. ^[1] ; Olson, Christine K. ^[2] ; Clark, Elizabeth ^[3] ; Marquez, Paige ; Strid, Penelope ; Ellington, Sascha ; Zhang, Bicheng ; Mba-Jonas, Adamma ; Alimchandani, Meghna ; Cragan, Janet ; Moore, Cynthia

作者单位： Ctr Dis Control & Prevent CDC ^[1] CDC ^[2] US EPA ^[3]

关键词 Adverse events Epidemiology Coronavirus COVID-19 mRNA vaccines SARS-CoV-2 Adenovirus type 26 Pregnancy Surveillance Vaccine safety PRACTICES INTERIM RECOMMENDATION UNITED-STATES ADVISORY-COMMITTEE WOMEN INCLUSION SAFETY

发布时间 2022-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020-October 2021

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020-October 2021

相似文献

相关期刊

检索历史清除